Mainz Biomed N.V. (MYNZ) Stock Could Soon Reward Patient Investors

Mainz Biomed N.V. (NASDAQ: MYNZ) is -76.77% lower on its value in year-to-date trading and has touched a low of $0.19 and a high of $3.39 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MYNZ stock was last observed hovering at around $0.24 in the last trading session, with the day’s gains setting it 0.03%.

Currently trading at $0.27, the stock is 1.78% and -15.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.34 million and changing 11.41% at the moment leaves the stock -62.20% off its SMA200. MYNZ registered -90.48% loss for a year compared to 6-month loss of -75.05%. The firm has a 50-day simple moving average (SMA 50) of $0.32004 and a 200-day simple moving average (SMA200) of $0.713065.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -17.46% gain in the last 1 month and extending the period to 3 months gives it a -43.87%, and is 8.23% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.15% over the week and 15.33% over the month.

Profit margin for the company is -2936.50%. Distance from 52-week low is 45.52% and -92.06% from its 52-week high. The company has generated returns on investments over the last 12 months (-595.61%).

with sales reaching $220k over the same period., but quarterly earnings will post 34.10% year-over-year. Quarterly sales are estimated to shrink -12.00% in year-over-year returns.

Mainz Biomed N.V. (MYNZ) Top Institutional Holders

The shares outstanding are 21.17M, and float is at 17.15M with Short Float at 4.20%.

The top institutional shareholder in the company is NORTHERN TRUST CORP with over 29934.0 shares valued at $12004.0. The investor’s holdings represent 0.1414% of the MYNZ Shares outstanding. As of 2024-06-30, the second largest holder is VONTOBEL HOLDING LTD. with 25000.0 shares valued at $10025.0 to account for 0.1181 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 15189.0 shares representing 0.0718% and valued at over $6090.0, while XTX TOPCO LTD holds 0.0537 of the shares totaling 11358.0 with a market value of $4555.0.